Clinical Study Of Naga Bhasma in the Madhumehi (Diabetic) Patients
Phase 2
Completed
- Conditions
- Health Condition 1: null- Patients having chief and associated complains of Madhumeha (Prabhuta Avilamutrata pipashadhikya kshudhadhikya etc)Known patient of Type 2 Diabetes Mellitus.Health Condition 2: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2017/05/008451
- Lead Sponsor
- Institute for Post Graduate Teaching and Research in Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 132
Inclusion Criteria
1) Patients having chief & associated complains of Madhumeha (Prabhuta-Avilamutrata, pipashadhikya, kshudhadhikya etc.)
2) Known patient of Type 2 Diabetes Mellitus and aslo the preliminarily diagnosed patients on the basis of signs and symptoms of the disease are confiremed by FBS and PPBS.
Exclusion Criteria
1) Age more than 60 and below 30 years
2) All patients of diabetes mellitus receiving insulin.
3) Malignanat and accelerated hypertensive.
4) CVS disorders (CAD)
5) CNS disorder e.g. encephalopathy
6) HIV positive cases.
7) Other chronic debilitating diseases like STD etc.
•Pregnant woman and planning to be pregnant within six month
•Lactating mothers.
•Secondary Diabetes mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary end-point was symptomatic relief, reduction and control of NIDDM symptoms, polydipsia, polyuria, polyphagia, burning sensation in hands and soles, pain/ cramps, fasting and postprandial blood sugar levels.Timepoint: After 3 months trial drugs intervention.
- Secondary Outcome Measures
Name Time Method aga Bhasma safety and toxicity profiles were secondary end points.Timepoint: 18 months